Cardiovascular surgery (London, England) · 1994
Assisted circulation in postcardiotomy heart failure: experience with the Bio-Medicus centrifugal pump in ten patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Paolini G, Triggiani M, Di Credico G, Pocar M, Stefano P, Montorsi E, Simeone F, Paolillo G, Grossi A
Аннотация
Between January 1990 and September 1992, ten patients required assisted circulation for postcardiotomy heart failure which was unresponsive to inotropic drugs and aortic counterpulsation. All patients were supported by a Bio-Medicus centrifugal pump (biventricular assist in five, left ventricular in three, right ventricular in two); six had ischaemic heart disease, two a congenital ventricular septal defect, one an acute mitral valve incompetence and one an aortic type 'A' dissection. The mean duration of circulatory support was 5.1 days (range 2 hours to 8 days). Six patients were weaned from the device and four were discharged; the perioperative deaths among the patients weaned from support were the result of cerebral haemorrhage and multiorgan failure respectively. No late deaths occurred at a mean follow-up of 15 months. Common complications were bleeding (40%), acute renal failure (30%) and sepsis (30%). All patients who developed renal failure died. The high incidence of haemorrhagic complications makes the use of pre-heparinized circuits desirable as these patients do not then require additional anticoagulation.
Предметные рубрики MeSH
Acute Kidney InjuryAgedAortic DissectionAortic AneurysmAssisted CirculationBacterial InfectionsCardiac Output, LowCardiac Surgical ProceduresCause of DeathCerebral HemorrhageChild, PreschoolEquipment DesignFemaleFollow-Up StudiesHeart Septal Defects, VentricularHeart-Assist DevicesHemorrhageHumansMaleMiddle AgedMitral Valve InsufficiencyMultiple Organ FailureMyocardial IschemiaSurvival Rate